Correlation Between Cansortium and Khiron Life

Can any of the company-specific risk be diversified away by investing in both Cansortium and Khiron Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cansortium and Khiron Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cansortium and Khiron Life Sciences, you can compare the effects of market volatilities on Cansortium and Khiron Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cansortium with a short position of Khiron Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cansortium and Khiron Life.

Diversification Opportunities for Cansortium and Khiron Life

-0.11

Correlation Coefficient

Cansortium  Khiron Life

Good diversification

The 3 months correlation between Cansortium and Khiron is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Cansortium and Khiron Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Khiron Life Sciences and Cansortium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cansortium are associated (or correlated) with Khiron Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Khiron Life Sciences has no effect on the direction of Cansortium i.e., Cansortium and Khiron Life go up and down completely randomly.

Pair Corralation between Cansortium and Khiron Life

Assuming the 90 days horizon Cansortium is expected to under-perform the Khiron Life. But the otc stock apears to be less risky and, when comparing its historical volatility, Cansortium is 21.15 times less risky than Khiron Life. The otc stock trades about -0.12 of its potential returns per unit of risk. The Khiron Life Sciences is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Khiron Life Sciences on September 15, 2024 and sell it today you would earn a total of  0.00  from holding Khiron Life Sciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cansortium  vs.  Khiron Life Sciences

Cansortium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cansortium has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Khiron Life Sciences

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Khiron Life Sciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Khiron Life reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cansortium and Khiron Life

The main advantage of trading using opposite Cansortium and Khiron Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cansortium position performs unexpectedly, Khiron Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Khiron Life will offset losses from the drop in Khiron Life's long position.

The idea behind Cansortium and Khiron Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.